An early-stage drug discovery company developing differentiated multi-specific antibodies for autoimmune diseases. Omni is led by a multidisciplinary team with deep expertise in immunology, antibody engineering & drug development. Our goal is to deliver durable disease control through systems-guided design leveraging validated targets, all while preserving immune function. Our business model expedites drug discovery & development while reducing costs with operations across Canada & China.